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Diazoxide, a nondiuretic benzothiadiazine deriva-
tive, administered as a bolus or infused slowly over
prolonged periods, has a strong antihypertensive
effect, due to relaxation of vascular smooth
muscle in the precapillary resistance vessels [13].
For this reason, diazoxide is recommended for the
management of hypertensive crises in pregnancy
[1, 8, 9, 14, 15, 18, 25, 28]. The antihypertensive
activity of the drug appears to be associated with
an increase in heart rate and cardiac output which
could be advantageous for the maintenance of
cerebral and renal blood flows [12, 25].
However, the objective to obtain rapid reduction
of blood pressure in pregnant patients with severe
hypertension in an effort to prevent damage to the
maternal brain and kidneys is complicated by the
desire to avoid adverse effects on the utero-
placental circulation leading to fetal compromise.
To maintain, or preferably increase, uterine blood
flow under a reduced arterial pressure would
require reduction of uteroplacental vascular
resistance. Some clinical data suggest that such an
effect does not occur following an intravenous
bolus of diazoxide, with the consequence of fetal
distress [20, 23]. Other studies, however; conclude
that immediate reduction of maternal arterial
pressure is without apparent hazard to the fetus
[1, 8, 14, 15, 18] in particular when blood pres-
sure is lowered gradually by slow infusion of
diazoxide [28] or by intermittent administration
of low doses [24].
For obvious reasons, the direct and indirect hemo-
dynamic effects of diazoxide on the uteroplacental
and fetal circulations cannot be assessed quantita-
tively in hypertensive women. Experimental
studies in various species of pregnant animals have
been reported in the literature but none of the
animals were hypertensive [3,6, 16, 17, 21]. Since
an experimental model of renovascular hyper-
tension, based on the GOLDBLATT-mechanism is
available in pregnant sheep [5] the present study
was designed to study the short-time maternal and
fetal hemodynamic effects of a bolus injection of
diazoxide in chronically instrumented normoten-
sive and hypertensive pregnant ewes.
1 Material and methods
All experiments were done in chronically instru-
mented pregnant ewes with a gestational age of
105—113 days and a single fetus as demonstrated
by X-ray examination. In six ewes one-kidney
renal hypertension was induced by the GOLD-
BLATT-mechanism; these ewes constitute Group H.
Five ewes served as controls (Group NH).
1.1 Surgical procedures
The ewes were starved for 12 hours prior to
surgery. Surgical anesthesia was obtained with
60 per cent nitrous oxide and 0.5—4 volume per
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cent enflurane in oxygen following tracheal
intubation and mechanical ventilation. The ewes
which were to become hypertensive (Group H)
were placed in a lateral position and a kidney was
approached retroperitoneally through an oblique
lumbar incision. The renal pedicle was divided
between hemostats and the kidney was removed.
A polyvinyl catheter was advanced into the
descending aorta through the stump of the renal
artery. The contralateral kidney was approached
in the same manner through a contralateral lumbar
incision. A calibrated electromagnetic flow trans-
ducer was placed around a portion of the renal
artery, carefully cleaned of adhering tissue, and an
inflatable cuff was fitted around the artery distal
to the flow transducer.
\ In the control animals (Group NH) an electro-
magnetic flow transducer was fitted around a
renal artery, the contralateral kidney was left
untouched. A polyvinyl catheter was introduced
into the descending aorta through a femoral artery.
The arterial catheter and the cable of the flow
transducer were tunneled subcutaneously to the
flank of the ewe, in one-kidney animals together
with the tubing from the inflatable cuff, and
placed in a pouch.
Renal arterial blood flow and arterial pressure
were monitored frequently after surgery. When
values were considered to be stable, usually two to
three days after surgery, renal blood flow in the
one-kidney animals was reduced by approximately
30% by inflating the cuff around the renal artery
with sterile oil. The animals were monitored daily
and renal arterial constriction was adjusted to
maintain 20—30% reduction in renal blood flow.
No experiments were done with the control
animals.
A second surgical procedure was performed in the
one-kidney animals as well as in the controls under
the same conditions one week after the first opera-
tion. A lower midline laparotomy was made, the
pregnant uterine horn was exposed, and access to
the fetus was obtained through a small myometrial
window. A polyvinyl catheter was inserted into
the fetal descending aorta through a femoral
artery. An electromagnetic flow transducer was
fitted around one umbilical artery close to the
fetal abdominal wall or, in some cases, around the
common umbilical artery via a retroperitoneal
approach [2].
Finally, the fetus was equipped with EGG elec-
trodes and the membranes and the uterine incision
were closed. An electromagnetic flow transducer
was placed around the main ascending branch of
the uterine artery supplying the pregnant horn. All
catheters and wires were brought out subcutane-
ously to the ewe's flank, and the abdominal inci-
sion was closed. Finally, a catheter was threaded
into a maternal jugular vein through a small
submandibular branch.
1.2 Experiments
Experiments were begun on the third day after the
last operation, and repeated every second or third
day. During the experiments the ewe was standing
quietly in a specially designed movable cage.
Flows, pressures and fetal ECG were continuously
recorded. Fetal heart rate was derived from the
ECG signal, maternal heart rate from the arterial
pressure curve. All signals were recorded on a poly-
graph and stored on magnetic tape. Uterine, renal,
and umbilical vascular resistances were calculated
by dividing the mean arterial blood pressure by the
blood flow in the uterine artery, the renal artery,
and the umbilical artery, respectively.
Following a control period of at least 30 minutes
during which stable signals were obtained, a dose
of 300 mg of diazoxide1 (approximately 5 mg per
kg of body weight) was administered intravenously
as a bolus over a period of 30—60 seconds. In a
number of experiments the injection of diazoxide
was combined with rapid venous infusion of a
plasma expander2; 250 ml were given just prior to
the injection of diazoxide, and 250 ml in the first
five minutes following the injection. The fetal and
maternal hemodynamic effects were recorded for
at least two hours following injection. Samples of
fetal and maternal arterial blood were drawn just
prior to injection and 30 and 120 minutes follow-
ing injection of diazoxide, for determination of
blood gases and acid-base status.
1 HYPERSTAT (Essex)
2 HAEMACCEL (Behring)
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Following the second operation the number
of animals available for study in both groups
decreased progressively due to obstruction of
catheters, transducer failure, development of
malignant hypertension with uremia, and fetal
death or premature delivery. A total of 17 experi-
ments could be performed in the six one-kidney
animals of group H, nine with and eigjit without
the use of plasma expander. In the five animals of
group NH 10 experiments could be done, four
with and six without plasma expansion.
All results are presented as means ± S. D. through-
out. Statistical analysis was done with appropriate
nonparametric tests for paired and unpaired
data, and p < 0.05 was chosen as the level of
significance.
2 Results
In the one-kidney ewes (Group H) mean arterial pres-
sure in the control period was 106 ± 9 mm Hg; in
the control group (Group NH)it was 75 ± 8 mm Hg,
which is significantly lower (p<0.01). Maternal
heart rate was 114 ±23 beats min""1 in group H,
which is significantly higher than that in group NH
(101 ± 8 beats min"1). Despite the fact that the
constrictor around the renal artery in group H was
adjusted daily to keep renal arterial blood flow
reduced by 20—30 per cent, the blood flow usually
rebounded quickly and eventually mean renal
arterial flow during the control periods in group H
(280 ± 66 ml min"1) was equal to that in group NH
(279 ± 76 ml min"1). However, due to the elevated
arterial pressure, mean renal arterial resistance in
group H (0.41 ± 0.13 mm Hg ml^1 min) was sig-
nificantly (p < 0.01) higher than that in group NH
(0.28 ±0.1).
The actual values of blood flow in the main uterine
artery showed marked differences between animals,
both in group H and in group NH, whidhuappeared
to be due in part to variations in the localization
of the flow transducer. Mean uterine artery flow
was 255 ± 114 ml min"1 in group H and 318 ± 145
in group NH, resulting in a mean uterine vascular
resistance of 0.42±0.2 mm Hg ml-1 min in group H
and of 0.21 ± 0.1 in group NH (p < 0.05).
There were no differences between the groups
with regard to fetal heart rate and fetal mean
arterial pressure in the control periods.
Since umbilical arterial flow was measured in
one umbilical artery in some animals and in the
common umbilical artery in others, the actual
values could not be compared. Mean values of fetal
pH (7.39) and pO2 (21.0 mm Hg) were equal in
both groups.
2.1 Diazoxide without plasma expander
Without the use of plasma expander, diazoxide
caused a rapid and significant fall in maternal
arterial pressure in both groups to approximately
50 per cent of control values (Tabs. I and II).
The maximum decrease was obtained within
10 minutes after injection. In particular in group H
the fall in diastolic pressure was more pronounced
than that in systolic pressure, pulse pressure
widened considerably. Two hours after injection
mean arterial pressure had returned to control
values in most normotensive ewes, but was still
significantly lower in the hypertensive group.
In both groups the fall in arterial pressure was
accompanied by a significant increase in mater-
nal heart rate, which was most pronounced in
group NH.
The relative changes in uterine and umbilical
arterial flows and calculated vascular resistances
are summarized in Tabs. Ill and IV. Uterine
arterial flows fell significantly and in parallel with
or somewhat steeper than the arterial pressures in
both groups. This resulted in an increase in mean
uterine vascular resistance which reached a signifi-
cant level at 30—60 minutes in group NH. In
group NH renal arterial blood showed a variable
response: In some cases it fell in parallel with the
decrease in arterial pressure, but in other experi-
ments there was evidence of autoregulation. In
hypertensive ewes which received diazoxide
without plasma expander, there was no evidence
of autoregulation of the renal circulation; renal
blood flow fell in parallel with the drop in arterial
pressure. In both groups no significant changes
were observed in fetal arterial pressure. Fetal heart
rate started to fall within five minutes following
administration of diazoxide to the ewe, and
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Tab. I. Maternal and fetal hemodynamic variables (mean ± S.D.) in normotensive ewesf before and after intravenous
administration of 300 mg of diazoxide.
without plasma
expander (n = 6)
with plasma































































































MHR Maternal Heart Rate (beats min-1)
MAP Maternal Mean Arterial Pressure (mm Hg)
RAF Renal Artery Flow (ml min-1)
RVR Renal Vascular Resistance (mm Hg ml-1 min)
FHR Fetal Heart Rate (beats min-1)
FAP Fetal Mean Arterial Pressure (mm Hg)
remained significantly decreased during the
following 10-15 minutes. Blood flow in the
umbilical artery showed a tendency to fall with a
rise in umbilical vascular resistance, but the
changes were not significant. Fetal pH showed an
average maximum fall of 0.09 in both groups,
and fetal arterial pO2 values were found to be
decreased by 2-6 mm Hg at 30 minutes after
administration of diazoxide. At 120 minutes fetal
pH and pO2 values had returned to control levels
in most cases.
2.2 Diazoxide with plasma expander
When plasma expander was given during injection
of diazoxide, mean arterial pressure in the normo-
Tab. II. Maternal and fetal hemodynamic variables (mean ± S.D.) in hypertensive ewes before and after intravenous
administration of 300 mg of diazoxide.
without plasma
expander (n = 8)
with plasma
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Tab. III. Blood flow and resistance in a main uterine artery and an umbilical artery in normotensive ewes after intra-
venous administration of 300 mg of Diazoxide, expressed as a percentage of control values (mean ± S.D.).
Minutes after administration of diazoxide
0-5 6-10 11-35 36-60 61-100
without plasma
expander (n = 6)
with plasma























































UtAF Uterine Artery Flow
UtVR Uterine Vascular Resistance
47 ±13 62 ±16
117 + 25 130 ±11
94 ± 39 76 ± 8
104 ±60 116 ±8
98 ± 8 85 ± 8
91 ± 8 101 ±15
104 ±11 104 ±10

























UmAF Umbilical Artery Flow
UmVR Umbilical Vascular Resistance
tensive ewe showed a small and non-significant one hour. The fall in arterial pressure was signifi-
decrease, and maternal heart rate increased (Tabs. I cantly less than that obtained with diazoxide
and II). In the hypertensive ewes, however, there without plasma expansion. Maternal heart rate
was a significant drop in mean arterial pressure to showed a significant, in some animals twofold,
80—85% of control values, which lasted at least increase which lasted at least two hours. In the
MAP





















Fig. 1. Intravenous bolus injection of 30 mg of diazoxide with plasma expansion in a normotensive ewe. Effects on
maternal arterial pressure (MAP), renal artery flow (MRAF), uterine artery flow (MUAF), fetal arterial pressure (FAP),
and umbilical artery flow (UAF).
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Tab. IV. Blood flow and resistance in a main uterine artery and an umbilical artery in hypertensive ewes after inter-
venous administration of 300 mg of Diazoxide, expressed as a percentage of control values {mean ± S.D.).
Minutes after administration of diazoxide
without plasma
expander (n = 8)
with plasma






















































normotensive as well as the hypertensive animals
renal blood flow showed a tendency to increase
during the first 10 minutes following administra-
tion of diazoxide, but the change was not signifi-
cant. A striking increase in systolic-diastolic flow
difference, was observed in all animals (Fig. 1
and 2). In both groups renal vascular resistance
showed a significant fall which lasted at least one
hour.
Mean uterine blood flow and resistance showed no
significant changes in normotensive animals. In


















Fig. 2. Intravenous bolus injection of 300 mg of diazoxide with plasma expansion in a hypertensive ewe Abbreviations
as in Fig. 1.
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of diazoxide combined with plasma expansion was
followed in the first 10 minutes by a significant
drop in uterine vascular resistance in the presence
of an unaltered or even increased blood flow in the
uterine artery (Tabs. Ill and IV).
In both groups no significant changes were observed
in fetal heart rate or fetal arterial pressure, nor in
blood flow and resistance in the umbilical artery.
Fetal pH and pO2 values at 30 and 120 minutes
remained stable.
3 Discussion
The chronically instrumented one-kidney hyper-
tensive sheep model used in this study shows
some pathophysiologic features of pregnancy-
induced hypertension as it occurs in humans: an
elevated blood pressure with an increased uterine
vascular resistance [7]. These findings are in agree-
ment with data reported by BRINKMAN [5] and
can be attributed, at least initially, to an increased
production of renin by the ischemic kidney [3].
Maintenance of the elevated arterial pressure
is supposed to depend on volume expansion,
increased cardiac output, and increased peripheral
resistance not caused by increased plasma renin
activity [3]. Our experiments do not allow any
conclusion about these mechanisms, since plasma
renin activity, plasma volume, and cardiac output
were not measured. However, the significantly
elevated maternal heart rate in the hypertensive
ewes is compatible with the presence of a hyper-
dynamic circulation. This would certainly consti-
tute a major difference with human pregnancy
complicated by preeclampsia in which intra-
vascular volume is usually contracted [27] and
cardiac output is low [11].
The experiments demonstrate that bolus injection
of diazoxide without simultaneous plasma expan-
sion in normotensive and hypertensive pregnant
ewes causes a rapid and protracted fall in mean
arterial blood pressure, with a concomitant fall in
renal and uterine blood flows. Accepting that the
fall in arterial blood pressure is due to dilatation of
peripheral resistance vessels [13], diazoxide
appeared to have no dilating effect on the renal
and uterine vasculature. In fact, in many experi-
ments, in particular in group NH, uterine vascular
resistance increased, because the decrease in
uterine blood flow was proportionately greater
than the fall in blood pressure. In normotensive
ewes these observations are in agreement with
findings reported by others [6, 21], and could be
explained by the fact that uterine vessels in
pregnant sheep are normally widely dilated and
function at maximum hemodynamic capacity,
with a very limited potential for further decrease
in vascular resistance [10]. For this reason, there
appears to be no effective autoregulation of the
uterine circulation by a further decrease in vascular
resistance in response to a decreased perfusion
pressure [29]. In addition, the acute hypotension
following administration of diazoxide, due to
systemic vasodilation with an increase in vascular
capacity resulting in a fall in effective circulating
blood volume, may lead to pathophysiologic
mechanisms which are known to be operative in
circulatory shock, in particular catecholamine
release. This would explain the observed increase
in uterine vascular resistance, since in sheep
marked uterine vasoconstriction has been shown
to occur with even minor alpha-adrenergic stimula-
tion [26]. This hypothesis is supported by our
finding that the demonstrated fall in uterine blood
flow in normotensive ewes caused by a bolus of
diazoxide can be prevented by simultaneous
plasma expansion. Volume expansion will abolish
the acute fall in effective circulating blood volume
and thus prevent secondary catecholamine release.
Also slow infusion of diazoxide has been reported
to cause no changes in uterine blood flow in
normotensive sheep, even in the face of markedly
reduced arterial pressures [6], most likely because
gradual endogenous volume shifts prevent the
acute reduction in effective circulating blood
volume which occurs following bolus injection.
In hypertensive ewes diazoxide combined with
plasma expansion appeared to significantly reduce
the elevated uterine vascular resistance, resulting in
a stable or even increased uterine arterial blood
flow. Diazoxide apparently does have a vasodilator
effect on uterine vasculature which is not max-
imally dilated, provided that circulating volume is
maintained.
It should be noted that in these experiments
central venous pressure was not measured. For
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that reason we used the mean arterial pressure and
not the actual perfusion pressure to calculate
vascular resistances. Volume expansion may have
caused an increase in venous pressure. Therefore,
in volume expanded, animals true vascular resist-
ances even may have been somewhat lower than
the resistances calculated on the basis of mean
arterial pressures alone.
Administration of diazoxide was accompanied
in both groups by a significant and rather pro-
tracted increase in maternal heart rate. Plasma
expansion appeared to have no influence on the
maternal cardioacceleration and experiments by
others indicate that it cannot be inhibited by beta-
adrenergic receptor blockade [19]. A 40—50 per
cent rise in maternal heart rate is also reported to
occur in preeclamptic patients treated with an
intravenous bolus of diazoxide and has been
attributed to a baroreceptor induced reflex tachy-
cardia [8, 18, 25]. The observation that tachy-
cardia also occurred in group NH, where diazoxide
with plasma expansion had virtually no effect on
arterial blood pressure, suggests that diazoxide
could also have a direct positive chronotropic
effect on the maternal heart.
Before and between experiments the renovascular
hypertensive state appeared to cause no fetal
distress: All fetal variables determined in the
control period in hypertensive ewes were com-
parable with those obtained in normotensive
controls. The fall in uterine blood flow caused by
a bolus injection of diazoxide without plasma
expansion was accompanied by moderate fetal
hypoxia with a decrease in fetal pH, although
overt fetal acidosis did not occur. These findings
are in agreement with those reported by others
[6, 16] and support existing experimental evid-
ence that the healthy sheep fetus can tolerate a
marked reduction in uterine blood flow without
signs of compromise [10]. However, it seems
likely that the transient fetal hypoxia must be held
responsible for the observed fall in fetal heart
rate which, under these circumstances, will result
in a fall in combined ventricular output [22].
Since in our experiments umbilical flow remained
rather stable, important redistribution of fetal
blood flows must have occurred, favoring the
placenta. Against the background of this data it
can be understood that, if the fetus is already
acidotic, a diazoxide-induced reduction in uterine
blood flow may result in progressive fetal deter-
ioration [16]. In both groups of experimental
animals plasma expansion appeared to prevent any
effect of an intravenous bolus of diazoxide on
fetal oxygenation and acid-base status, most likely
because uterine blood flow was maintained or even
increased in the face of a marked reduction in
mean arterial pressure.
In conclusion, the results of the present experi-
mental study support the clinically demonstrated
efficacy of an intravenous bolus of diazoxide in
lowering maternal blood pressure in hypertensive
pregnancy. Although we recognize the dangers and
limitations of extrapolating our data to pre-
eclampsia in human pregnancy, it is conceivable
that fetal distress reported to occur following
bolus injection of diazoxide in preeclamptic
patients [20, 23] is due to a fall in uteroplacental
blood flow, which may be" prevented by plasma
expansion. In preeclamptic patients the decrease in
effective circulating volume following diazoxide
may even be expected to be more pronounced
than in one-kidney hypertensive ewes, because of
the contracted plasma volume in this condition.
Summary
Diazoxide is a potent antihypertensive agent due to its
peripheral vasodilator action. For this reason it is used in
the management of hypertensive crises in pregnancy. To
assess the effects of an intravenous bolus injection of
diazoxide on maternal and fetal hemodynamics an experi-
mental study was performed in 11 chronically instru-
mented pregnant sheep. In six ewes hypertension was
induced by surgical removal of one kidney and reduction
of arterial blood flow to the remaining kidney (one-
kidney renovascular hypertension). The other five ewes
remained normotensive. In a second .operation, one
week after the first one, the animals were equipped
with electromagnetic flow transducers and catheters for
monitoring of blood flow in a renal, a uterine, and an
umbilical artery and for measurement of maternal and
fetal arterial blood pressures, and blood sampling. Mater-
nal heart rate was derived from the arterial pressure curve,
fetal heart rate from a fetal ECG.. Experiments were
begun on the third day after the second operation. In
each experiment a bolus of 300 mg of diazoxide was
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administered intravenously, with or without rapid simul-
taneous infusion of 500 ml of a plasma expander. A total
of 17 experiments were performed in the one-kidney
hypertensive ewes (Group H), nine with and eight without
plasma expander. In the five normotensive animals
(Group NH) 10 experiments were done, four with and six
without plasma expansion. During the control periods
maternal arterial pressure was approximately 30 mm Hg
higher in Group H than in Group NH. In Group H also
maternal heart rate, and renal and uterine vascular resist-
ances were significantly elevated. All fetal variables were
equal in both groups. Administration of diazoxide with-
out simultaneous plasma expansion resulted in both
groups in a significant fall in maternal arterial pressure, a
rise in maternal heart rate, and a fall in uterine and renal
blood flows with a rise in vascular resistance. Fetal
arterial pressure and umbilical blood flow showed no
significant changes, but fetal heart rate showed a transient
fall together with a drop in fetal pC>2 and pH, although
acidosis did not occur. When diazoxide was combined
with a plasma expander maternal blood pressure did not
change significantly in Group NH, but fell in Group H.
Maternal heart rate rose significantly in both groups. The
decrease in uterine and renal blood flows which occurred
when diazoxide was given without plasma expansion
was not observed. In particular in Group H renal and
uterine vascular resistances showed a significant fall. Fetal
variables showed no change. These results indicate that
diazoxide is a potent vasodilator, and that its circulatory
effects are dependent on the maintenance of an effective
circulating blood volume. Administration of an intra-
venous bolus of diazoxide leads to a sudden rise in vascu-
lar capacity with a decrease in effective circulating volume
resulting in a fall in renal and uterine blood flows. The
decrease in uteroplacental perfusion can be compensated
by a healthy but most likely not by an acidotic fetus.
These undesirable effects of diazoxide are prevented by
simultaneous plasma expansion. It is concluded that the
adverse effects of diazoxide on the fetus reported in
preeclamptic patients may be due to the experimentally
demonstrated fall in uteroplacental blood flow, which
may be prevented by simultaneous plasma expansion.
Keywords: Experimental hypertension, diazoxide, Goldblatt-hypertension, volume expansion.
Zusammenfassung
Mütterliche und fetale Kreislaufwirkungen nach Diazoxid
bei normotensiven und hypertensiven trächtigen Schafen
Diazoxid gilt wegen seiner peripheren vasodilatatorischen
Wirkung als potentes Antihypertensivum. Aus diesem
Grund wird es auch bei hypertensiven Krisen in der
Schwangerschaft angewandt. Um die hämodynamischen
Auswirkungen eines intravenösen Diazoxidbolus sowohl
auf die Mutter wie auf den Feten zu erfassen, wurde
eine experimentelle Studie an 11 dauerüberwachten
trächtigen Schafen durchgeführt. Bei 6 Schafen wurde
der Hypertonus durch die Nephrektomie einer Niere und
Reduktion des arteriellen Zuflusses der verbleibenden
Niere induziert (renovaskulärer Hypertonus bei einer
Niere). Die anderen 5 Schafe waren normotensiv. In einer
zweiten Operation nach einer Woche wurden die Tiere mit
elektromagnetischen Transducern und Kathetern zur
Messung und Überwachung des renalen, uterinen und
umbilikalen Blutflusses sowie des maternalen und fetalen
arteriellen Blutdrucks, versehen. Auch Blutentnahmen
waren auf diesem Weg möglich. Die maternale Herzfre-
quenz leiteten wir aus der arteriellen Druckkurve ab, die
fetale Frequenz aus dem ECG. 3 Tage nach der zweiten
Operation haben wir mit den Experimenten begonnen.
Dabei wurden jeweils 300 mg Diazoxid intravenös verab-
reicht, zum Teil unter gleichzeitiger, rascher Infusion von
500 ml Plasmaexpander. Insgesamt wurden in dem hyper-
tensiven Kollektiv (Gruppe H) 17 Versuche durchgeführt,
davon 9 mit und 8 ohne Plasmaexpander. Bei den 5 nor-
motensiven Schafen (Gruppe NH) wurden 10 Experi-
mente durchgeführt, davon 4 mit und 6 ohne Plasma-
expander. Während der Kontrollperioden lag der artierielle
Druck in der Gruppe H um etwa 30 mmHg höher als in
der Gruppe NH. Auch die maternale Herzfrequenz sowie
die renale und uterine Resistance waren in der Gruppe H
signifikant erhöht. Die fetalen Parameter waren in den
beiden Gruppen vergleichbar. Nach Gabe von Diazoxid
ohne Plasmaexpander erfolgte in beiden Gruppen ein
signifikanter Abfall des mütterlichen arteriellen Druckes,
ein Anstieg der maternalen Herzfrequenz und ein Abfall
des uterinen und renalen Flows bei Erhöhung des vasku-
lären Widerstands. Der fetale arterielle Druck und der
umbilikale Flow zeigten keine signifikanten Verände-
rungen, die fetale Herzfrequenz sank jedoch vorüber-
gehend zusammen mit einem Abfall des fetalen pU2 und
pH ab, ohne daß eine Azidose auftrat. Bei gleichzeitiger
Gabe von Plasmaexpander fiel der maternale, arterielle
Druck in der Gruppe NH nach Diazoxid nicht ab, wohl
aber in der Gruppe H.
Hinsichtlich der mütterlichen Herzfrequenz kam es in
beiden Gruppen zu einem signifikanten Anstieg. Es
erfolgte kein Abfall des uterinen und renalen Flows wie er
nach Gabe von Diazoxid ohne Plasmaexpander zu beob-
achten war. In der Gruppe H kam es zu einem signifikan-
ten Abfall der renalen und uterinen Resistance. Die
fetalen Parameter änderten sich nicht. Die Ergebnisse
zeigen, daß Diazoxid ein potenter Vasodilatator ist,
dessen Kreislaufwirkung von der Aufrechterhaltung des
effektiv zirkulierenden Blutvolumens abhängt. Die Gabe
eines intravenösen Diazoxidbolus führt zu einer plötzli-
chen Erweiterung der Gefäßkapazität und einem Abfall
des effektiv zirkulierenden Volumens, was einen reduzier-
ten renalen und uterinen Flow zur Folge hat. Die Ein-
schränkung der utero-plazentaren Perfusion kann durch
einen gesunden Feten kompensiert werden, nicht aber
durch einen azidotischen Feten. Dieser unerwünschte
Effekt des Diazoxids kann durch gleichzeitige Plasma-
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expanderinfusion verhindert werden. Wir schließen aus
unseren Experimenten, daß nachteilige Wirkungen auf den
Feten nach Einsatz von Diazoxid bei präeklamptischen
Patientinnen, von den berichtet wurde, auf den experi-
mentell nachvollzogenen Abfall des utero-plazentaren
Flows zurückzuführen siricf. Dieser Abfall kann durch
Gabe von Plasmaexpander verhindert werden.
Schlüsselwörter: Diazoxid, experimenteller Hypertonus, Goldblatt-Hypertonus, Volumenauffullung.
Resume
Effets du diazoxide sur les circulations maternelles et
fetales chez les brebis gravides normotendues et hypei-
tendues
Le diazoxide est un agent antihypertenseur puissant du
fait de son action vasodilatatrice peripherique. Pour cette
raison, on Futilise dans le traitement des poussees hyper-
tensives de la grossesse. On a realise une etude experi-
mentale sur 11 brebis gravides appareillees en continu
pour determiner les effets de l'injection intra-veineuse
d'embols de diazoxide sur l'hemodynamique maternelle
et foetale. Chez 6 brebis, l'hypertension a ete induite par
Fexerese chirurgicale d'un rein et par la reduction du flux
sanguin arteriel au rein restant (hypertension renovascu-
laire sur rein unique). Les 5 autres brebis sont demeurees
normotendues. Par une seconde intervention, une semaine
apres la premiere, les animaux on t ete appareilles de
capteurs de flux electromagnetiques et de catheters pour
surveiller le debit sanguin arteriel r6nal, uterin et ombilical,
pour mesurer les pressions arterielles maternelles et foetales
et pour effectuer des prelevements sanguins. On a deter-
mine le rythme cardiaque maternel a partir de la courbe
de pression arterielle et le rythme cardiaque foetal ä partir
de l'E.C.G. foetal. Les experimentations ont debute le
troisieme jour apres la seconde intervention. Au cours de
chaque experience on a injecte en intra-veineux un
ensemble de 300 mg de diazoxide, avec ou sans perfusion
simultanee rapide de 500 ml d'un extenseur plasmatique.
Au total, 17 experimentations ont ete realisees chez les
brebis hypertendues ä rein unique (groupe H), neuf avec
extenseur plasmatique et huit sans. Dans le groupe des
animaux normotendus (groupe NH) on a realise 10 expe-
rimentations, 4 avec expansion plasmatique et 6 sans.
Pendant les periodes de controle, la pression arterielle
maternelle etait aproximativement plus elevee de
30 mm de Hg dans le groupe H que dans le groupe NH.
Egalement, dans le groupe H, le rythme cardiaque mater-
nel ainsi que les resistances vasculaires renales et uterines
etaient eleves de fagon significative. Toutes les variables
foetales etaient equivalentes dans les deux groupes.
L'injection de diazoxide sans expansion plasmatique
simultanee a entraine dans chaque groupe une chute
significative de la pression arterielle maternelle, une
elevation du rythme cardiaque maternel et une diminu-
tion des debits sanguins uterin et renal avec augmentation
des resistances vasculaires. II n'y a pas eu de modification
significative de la pression arterielle foetale ni du debit
sanguin ombilical, mais le rythme cardiaque foetal a
presente un ralentissement transitoire en meme temps
qu'apparaissait une baisse de la pO2 foetale et du pH sans
neanmoins apparition d'acidose. Lorsque Finjection de
diazoxide a ete associee ä une expansion plasmatique
maternelle, il n'y a pas eu de modification significative de
la pression arterielle maternelle dans le groupe NH, mais
est apparue une chute dans le groupe H.
Le rythme cardiaque maternel s'est eleve dans chaque
groupe. On n'a pas observe la diminution des debits
sanguins uterin et renal survenue lorsque le diazoxide
avait ete administre sans expansion plasmatique. Les
resistances vasculaires renale et uterine ont montre une
chute significative en particulier dans le groupe H. Les
parametres foetaux ne se sont pas modifies. Ces resultats
indiquent que le diazoxide est un vasodilatateur puissant
et que ses effets circulatoires sont sous la dependance du
maintien du volume sanguin circulant. L'injection intra-
veineuse d'un embol de diazoxide entraine une e!6vation
rapide de la capacite vasculaire avec une diminution du
volume circulatoire effectif entrainant une chute du debit
sanguin renal et uterin.
La diminution de la perfusion utero-placentaire peut etre
compensee par un foetus en bonne sante, mais vraissemb-
lablement pas par un foetus en acidose. Ces effets indesi-
rables du diazoxide sont evites par une extension plasma-
tique simultanee. On en conclut que les effets nocifs du
diazoxide sur le foetus rapportes chez des patientes pre-
eclemptiques peuvent etre secondaires a la chute demon-
tree experimentalement du debit sanguin utero-placen-
taire, chute qui peut etre evitee par une extension plasma-
tique simultanee.
Mots-cles: Diazoxide, extension volumetrique, hypertension de Goldblatt, hypertension experimentale.
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